Introduction
Cells die for dierent reasons: they become damaged, they are told to die by other cells, or they are deprived of survival signals. Although it is the fate of every cell to die, it is crucial to the survival of the organism that cell death is regulated. Inappropriate cell death is as detrimental to the organism as inappropriate cell division. The process by which cells sense extracellular stimuli, amplify localized signals, and integrate information is called signal transduction. Every step in such a complex series of enzymatic events is a potential point of regulation. Thus, apoptosis is a highly regulated cellular response with checkpoints along the commitment path. Each of these enzymatic steps is also a potential point of intervention for the clinician. The control of apoptosis in the clinic is already exploited in chemotherapy and radiation therapy for the treatment of cancer. Greater control of cell death will mean viable treatments for immune disorders and neurodegenerative diseases. Excellent reviews have been recently written covering those events proximal to the actual death of the cell, including the complex interactions of members of the Bcl-2 family (Williams and Smith, 1993) and the ®nal convergence of signals on the cells executioners, the caspases (Nagata, 1997) . Upstream of this apoptosis machine lie the signal transduction pathways that ensure that the fate of the cell is bene®cial to the organism. In vitro studies using cultured cells and in vivo experiments with knockout mice have identi®ed biochemical pathways that are pro-apoptotic, and other pathways that are anti-apoptotic.
Pro-apoptotic stimuli
Under physiologic conditions in the organism, apoptosis is normally initiated by three types of stimuli: the deprivation of survival factors, signals through apoptotic receptors, or cell damaging stress. These three types of stimuli have been duplicated in tissue culture model systems to reveal that quite dierent signal transduction pathways can mediate a common end result.
Growth factor withdrawal is commonly studied in PC12 pheochromocytoma cells (Xia et al., 1995; Mesner et al., 1992) . If these cells are incubated with NGF, they dierentiate into neuronal cells. If NGF is then withdrawn in the absence of serum, the cells will undergo apoptosis. This model system is thought to mimic the death of extraneous neurons in the developing nervous system (Henderson, 1996) . Factor deprivation can also induce apoptosis in hematopoietic cells, many of which are dependent on IL-2 or other factors for survival (Cohen et al., 1992) . Anoikis is the name given to cell death induced by deprival of survival signals from the extracellular matrix (Ruoslahti and Reed, 1994; Frisch et al., 1996) . In the colon, epithelial cells undergo anoikis when they migrate to the tip of the microvillus and are sloughed o.
Receptors on the cell surface can cause apoptosis when engaged by their ligands. Fas is the most widely expressed and the most universally eective example of the death receptors. Fas is expressed on nearly all cells, and ligation of Fas by anti-Fas IgM or by the natural ligand induces apoptosis in virtually all systems tested. Other cell surface receptors can induce apoptosis in a more limited range of cell types. TNF-a, whose receptor is related to Fas, can induce apoptosis in myelogenous leukemia and other cancer cells (Schmid et al., 1986) but acts as a growth inducing agent in ®broblasts (Vilcek et al., 1986) . Other members of this family have been cloned, including the TRAIL receptor, Apo-2 (Pitti et al., 1996) , which may have implications for cancer therapeutics in the future (Pan et al., 1997; Sheridan et al., 1997) . In the immune system, ligation of antigen receptors in T-cells and Bcells can cause apoptosis in the absence of a costimulatory signal through a second receptor (Ivanov and Nikolic-Zugic, 1997; Valentine and Licciardi, 1992; Musci et al., 1997) .
Cell stress can come in several forms in the physiologic state and even more forms of stress are perpetrated on cells in culture. Stimuli as diverse as ionizing radiation, osmotic shock, and microtubule disruption or stabilization can all induce an apoptotic response. Irradiation and DNA damaging chemicals are employed in cancer chemotherapy to induce apoptosis selectively in tumor cells while normal cells growth arrest.
Multiple signal transduction intermediates interacting in concert and in opposition ensure that under normal physiologic conditions, cells enter the apoptotic pathway only when it is bene®cial to the organism. Such a complex decision requires an equally complex integration of biochemical pathways.
Pro-apoptotic signal transduction pathways
Analysis of tissue culture model systems and knockout mice has begun to identify signal transduction pathways that are sucient, or necessary, for apoptosis. Certain kinases have been identi®ed that are able to cause apoptosis when expressed in cells. A subset of these kinases have been shown to be necessary for the induction of apoptosis in response to a stimulus. An examination of several studies, many with apparently con¯icting results, reveals that a complex integration of signal transduction pathways is involved in the decision of the cell to undergo apoptosis. In spite of the sizable gaps in our knowledge, a pattern of this integration is beginning to emerge.
c-Abl is a multifunctional tyrosine kinase located in the nucleus and cytoplasm that is activated by genotoxic agents such as 1-b-D arabinofuranosylcytosine (ara-C) and gamma irradiation, but not by ultraviolet radiation (Kharbanda et al., 1995a,b) . c-Abl has been shown to interact with proteins involved in cell cycle control and the response to DNA damage (Brown and McCarthy, 1997) . It may be activated by direct association with ATM, a kinase involved in the sensing of DNA damage (Enoch and Norbury, 1995) . Among the eectors of c-Abl are p53 and the retinoblastoma gene product Rb, which mediate cell cycle arrest and apoptosis. Transient expression of c-Abl, but not kinase-inactive c-Abl, has been shown to induce apoptosis of MCF-7 human breast carcinoma cells . Cells expressing kinase-inactive c-Abl exhibited resistance to ionizing radiation-induced apoptosis. Finally, cells null for c-Abl (abl
) also appeared impaired for apoptosis. This action of c-Abl in enhancing apoptosis may be related to several actions of the Abl tyrosine kinase including its regulation of DNA-PK (Kharbanda et al., 1997) and activation of the JNK pathway (Kharbanda et al., 1995a) .
MKK3 and MKK6 are upstream activators of p38/ Hog kinase, a stress and cytokine induced mitogenactivated protein kinase member. The immediate upstream regulators of p38/Hog, MKK6 and, to a lesser extent MKK3, appear to play a central role in Fas mediated apoptosis in Jurkat cells Juo et al., 1997) . Activated mutants of both MKK3 and MKK6 potentiate apoptosis in Jurkat cells in response to Fas ligation and cause apoptosis by themselves. A mutant of MKK6b that lacks phosphorylation sites, and thus prevents activation of the native kinase, inhibits the induction of apoptosis by Fas. Thus, MKK6b activity is both sucient and necessary for receptor mediated apoptosis. Cell permeant inhibitors of caspases can prevent the activation of MKK6b, and can prevent MKK6b induced cell death, suggesting that caspases lie both above and below the level of MKK6b. Inhibition of p38/Hog did not block the Fas induced or MKK6b induced apoptosis demonstrating that whatever the mechanism by which MKK6b mediates apoptosis, its ability to activate p38 may be irrelevant.
MEKK1 is a 196 kDa kinase activator of the ERK and JNK pathways. Overexpression of the kinase domain of this protein causes apoptosis in many cell types Xia et al., 1995) . Like MKK6b, the position of MEKK1 in the apoptotic pathway lies both upstream and downstream of the caspases. It was recently demonstrated that MEKK1 is a substrate for caspase-3-like proteases (Cardone et al., 1997) and the kinase activity of MEKK1 stimulates caspase-3-like activity in cells (Widmann et al., 1998) . A mutant of MEKK1 that is resistant to caspase cleavage is less capable of inducing apoptosis than the full length wild type protein, demonstrating that caspase cleavage of MEKK1 accelerates its apoptotic activity. Thus, MEKK1 and caspases exist in a feedback loop, in which the kinase activity of MEKK1 stimulates caspases, and caspase cleavage of MEKK1 enhances apoptosis.
Just as p38 activation is not necessary for MKK6b induced apoptosis, JNK activation is not solely responsible for the apoptosis induced by the kinase domain of MEKK1 . Coexpression of an inhibitory mutant of JNK kinase (JNKK or SEK-1), the kinase which lies between MEKK1 and JNK, was unable to inhibit MEKK1 induced apoptosis. MEKK1 clearly has other roles in the cell besides JNK activation, such as activation of the caspases.
MEKK1 cleavage plays a role in all three types of apoptosis. Cleavage of the native protein is seen in the response of cells to genotoxic agents, Fas ligation, and detachment of cells from the substrate (anoikis). Kinase inactive MEKK1, which inhibits the activity of the native kinase, inhibits cell death in response to detachment and genotoxic stress. Thus, MEKK1 contributes to apoptosis in at least two systems.
The small molecular weight GTP binding protein associated kinase PAK is a caspase substrate as well, and kinase inactive PAK-2 inhibits many of the morphological changes in apoptotic cells, without aecting DNA degradation (Rudel and Bokoch, 1997) . The dissociation of morphological events and DNA degradation points to the existence of a branch point between these pathways in the apoptosis response. These ®ndings suggest that PAK-2 acts late in the apoptotic pathway, downstream of most of the other biochemical events discussed in this review.
Crk is an adapter protein that contains both SH2 and SH3 domains. Making use of an in vitro model system of apoptosis, Evans et al. (1997) examined the role of phosphotyrosine SH2 domain interactions in the apoptotic response in Xenopus egg extracts. Previous studies had suggested that signaling pathways for apoptosis rapidly increased the phosphotyrosine content in cells. Recombinant SH2 domains encoded in dierent proteins were added to Xenopus egg extracts. The SH2 domain from Crk but not from Abl, Grb2, Lck, Ras GAP, PLCg or Nck inhibited nuclear condensation in the egg extracts. Immunodepletion of Crk also inhibited the extract apoptotic response. The ®ndings indicated that an SH2 domain binding phosphotyrosine-protein(s) in the extract that bound to Crk was required for the apoptotic response. The Crk SH3 domain also inhibited apoptotic signaling, suggesting both SH2 and SH3 domain binding proteins are required for the egg extract response. The exact Crk interacting proteins involved in the egg extract apoptotic response have not been identi®ed. De®ned Crk interacting proteins include Shc, Abl, and paxillin, as well as two Ras exchange proteins Sos and C3G. These ®ndings de®ne Crk as an adapter protein between tyrosine phosphorylation of speci®c proteins and the recruitment of pathways controlling apoptosis.
Other kinases which are able to cause apoptosis upon overexpression include PITSLREb1 (Lahti et al., 1995) , PKCd (Emoto et al., 1995; Ghayur et al., 1996) and ASK1 (Ichijo et al., 1997) . PITSLREb1 and PKCd are substrates of caspases during apoptosis. ASK1 kinase dead mutants are able to block TNF-a induced apoptosis in mink lung epithelial cells.
c-Jun N-terminal kinase, or JNK and p38/HOG are activated by many of the same stimuli that induce apoptosis. Many of the kinases that can induce apoptosis, cAbl, MKK3/MKK6, MEKK1 and ASK1, are upstream activators of stress activated protein kinases (SAPKs) JNK and p38. In spite of these correlations, however, it is not clear that the SAP kinases are directly involved in inducing apoptosis. It has been shown that the activation of p38 is not necessary for the induction of apoptosis by MKK3 or MKK6 , and that the activation of JNK is not necessary for the induction of apoptosis by the kinase domain of MEKK1 . It has never been shown that simple overexpression of JNK or p38 alone can cause cells to undergo apoptosis. One study that makes this claim showed that JNK can induce apoptosis when co-expressed with MEKK1 (Goillot et al., 1997) . The fact that MEKK1 alone can induce apoptosis makes this claim suspect. There is evidence that in certain circumstances inhibition of JNK associated signals can block the induction of apoptosis, possibly making it necessary, but not sucient for the activation of apoptosis.
Several studies have shown that inhibition of JNK activity, with competitive inhibitory mutants of JNK, its downstream target c-Jun, or its upstream activator JNKK, can inhibit apoptosis. In three model systems for survival factor withdrawal induced apoptosis, JNK was determined to be necessary: in NGF withdrawal from PC12 cells (Xia et al., 1995) and sympathetic neurons (Ham et al., 1995) and in anoikis of MDCK cells (Frisch et al., 1996) .
As is the case for survival factor withdrawal, there is evidence that JNK activity is necessary for stress induced apoptosis. There is a correlative relationship between JNK activation and the induction of apoptosis by genotoxic agents. Verheij et al. (1996) demonstrated that a kinase-inactive JNKK and an inhibitory form of c-Jun (TAM-67) could suppress stress-induced apoptosis. Using U937 and bovine aortic endothelial cells it was shown that kinase-inactive JNKK acted as a competitive inhibitory mutant and suppressed JNK activation. The kinase-inactive JNKK also suppressed the apoptotic response to C2-ceramide, ionizing radiation, H 2 O 2 , UV-C, heat shock and TNF-a. In HEK 293 cells, expression of JNK-APF (a nonactivatable mutant of JNK) and MEKK1-KR (an inactive mutant of MEKK1) inhibitory mutants partially blocked apoptosis induced by gamma irradiation and UV-C . JNK activity has also been implicated in the stimulation of caspase activity in U937 cells treated with etoposide or camptothecin (Seimiya et al., 1997) . Pretreatment of these cells with an antisense oligonucleotide that inhibits JNK expression suppressed caspase activation and apoptosis induced by these drugs.
In apparent contradiction to these ®ndings, there have been reports that JNK is either not involved in stress induced apoptosis, or that it is protective. This contradiction may be explained by the method used to inhibit JNK activity. The expression of an inhibitory mutant of c-Jun did not aect apoptosis caused by ionizing radiation in SQ-20-B human tumor cells (Hallahan et al., 1995) , and similar mutants protected T98G glioblastoma cells against cisplatin induced apoptosis (Potapova et al., 1997) . Therefore, in some instances the inhibition of c-Jun activation does not protect cells from apoptosis, while in other systems, inhibition of this transcription factor can protect cells (Verheij et al., 1996) . The spectrum of stress induced genes that are regulated by c-Jun and the other downstream eectors of JNK, such as ATF-2 or other as yet unidenti®ed substrates may play a central role in determining the ultimate fate of the cell.
It is in the area of receptor mediated apoptosis that the necessity for JNK activation is most controversial. In SHEP neuroblastoma cells, the expression of JNKAPF inhibited Fas mediated JNK activation and apoptosis, suggesting that JNK is necessary for Fas mediated killing (Goillot et al., 1997) . However, in Jurkat cells, the expression of an inhibitory c-Jun (TAM-67) or an inhibitory SEK-1 (SEK-1 KR) had no eect on Fas induced apoptosis (Lenczowski et al., 1997) . TNF-a, which acts through a receptor similar in structure to Fas, also activates JNK and causes apoptosis in many cell types, including MCF7 and HeLa cells. Interruption of signals downstream of the TNF receptor (TNFR1) can dissociate apoptosis from JNK activation (Liu et al., 1996) . The necessity of JNK activation in receptor mediated apoptosis is therefore dependent on the type of cell and the nature of the signal.
The recent cloning of the Fas interacting protein Daxx might explain the dierent JNK requirement for Fas mediated killing in dierent cell types (Yang et al., 1997) . Daxx can activate JNK when overexpressed, and can also potentiate apoptosis caused by Fas ligation. A dominant negative Daxx blocked JNK activation completely, but only partially blocked apoptosis. Another Fas binding protein, FADD, does not activate JNK, nor does the dominant negative mutant of FADD block JNK activation by Fas ligation. Dominant negative FADD can also partially block apoptosis, and FADD expression induces apoptosis in L929 cells. The mechanism that is suggested by this data is that Fas mediated apoptosis occurs through two parallel pathways, one initiated by Daxx binding that is JNK dependent and inhibited by Bcl-2, and another initiated by FADD binding that is JNK independent and is unaected by Bcl-2. The dominant pathway in a given cell will determine the JNK dependence of Fas mediated killing.
The role of JNK in apoptosis was also examined indirectly in a knockout experiment (Nishina et al., 1997) . The elimination of an upstream activator of JNK, SEK-1, by gene inactivation yielded ES cells with a substantially impaired JNK response to anisomycin. These cells displayed a normal apoptotic response to anisomycin, suggesting either that this small residual activation of JNK was sucient to mediate apoptosis or that JNK is not involved in apoptosis at all. SEK-17/7 thymocytes were generated in mice and tested for Fas and CD3 induced apoptosis. While heat shock caused apoptosis in these cells in a manner identical to the induction of apoptosis in SEK-1 expressing thymocytes, the knockout cells displayed an increased sensitivity to CD3 and Fas mediated apoptosis. Therefore, the upstream JNK activator SEK-1 can have a protective role in receptor mediated apoptosis.
Anti-apoptotic stimuli
Many cytokines and growth factors have protective actions and prevent apoptosis. Neurotrophic factors like NGF prevent apoptosis of neurons (Mesner et al., 1992) . FGF-2, PDGF and IGF-1 can protect fibroblasts and other cell types from apoptosis (Resnico et al., 1995) . CD40 protects B cells from apoptosis in response to ligation of the B cell antigen receptor (Valentine and Licciardi, 1992; Holder et al., 1993) and CD28 plays a similar role in T cells (Ward, 1996) . The EGF receptor when overexpressed also appears capable of mediating anti-apoptotic responses (Kulik et al., 1997) . The overexpression of EGF receptor family members is a common characteristic of many adenocarcinomas and is frequently an indicator of poor prognosis (Hynes and Stern, 1994) . The potential anti-apoptotic eect of autocrine/paracrine systems involving EGF receptors and their ligands would contribute signi®cantly to their growth and resistance to antineoplastic drugs. Like most other signals involved in the apoptotic response, many of these anti-apoptotic stimuli can also promote apoptosis under the right circumstances. CD28 ligation augments T-cell receptor induced apoptosis of immature (CD4+CD8+) T-cells in the thymus (Punt et al., 1994) and EGF causes apoptosis in certain breast cancer cell lines (Gulli et al., 1996) .
Anti-apoptotic signal transduction pathways
Apoptosis can be prevented by direct inhibition of caspase activity, by inhibiting the pro-apoptotic signal at some intermediate regulatory step, or by eliminating the apoptotic stimulus altogether. Each of these mechanisms is employed by the anti-apoptotic signaling pathways. There is evidence in dierent cell types that anti-apoptotic responses can be mediated by phosphatidylinositol 3-kinase (PI3K) and the Akt/ PKB serine-threonine protein kinase, p42/p44 mitogen-activated protein kinases or extracellular response kinases (ERKs), Raf, and cyclic AMP-dependent protein kinase (PKA).
ERKs are activated by diverse cytokines, growth factors, hormones, neurotransmitters, matrix proteins and other stimuli. Several studies have suggested that in a subset of cell types activation of ERK can protect against pro-apoptotic stimulants. This has been shown, for example, with serum deprivation-induced apoptosis of PC12 cells (Xia et al., 1995) , TNFa-induced apoptosis of L929 cells and UV-induced apoptosis of human primary neutrophils (Frasch et al, 1998) . The ERK substrates involved in the survival response are not known for any of the systems so far studied. Inhibition of apoptosis by ERKs is, as is often the case in this ®eld, cell type and stimuli dependent. In Rat-1 ®broblasts the ERK pathway did not appear to be involved in the protection against apoptosis in response to UV irradiation (Kulik et al., 1997) . In cerebellar neurons, IGF-1 promotes survival independently of ERK activation through activation of PI3K (Dudek et al., 1997) .
PI3K activity is induced by many of the antiapoptotic stimuli mentioned above. PI3K is recruited to the EGF receptor and other tyrosine kinase receptors upon ligand binding, and it is activated by CD40 in B cells. Cooper and co-workers ®rst showed in PC12 cells that PI3K activity was required for the survival of serum-deprived PC12 cells (Yao and Cooper, 1995) . Since these initial studies it has been shown that PI3K is protective against serum deprivation of ®broblasts (Kennedy et al., 1997) , UV irradiation of ®broblasts (Kulik et al., 1997) and cMyc-induced apoptosis (Kaumann-Zeh et al., 1997) .
The PI3K-mediated survival response has been shown in each of the above examples to be the result of Akt/PKB activation. Akt/PKB is a serine-threonine protein kinase activated by phosphatidylinositol 3, 4-P 2 (PtdIns-3,4-P 2 ) (Konishi et al., 1996; Klippel et al., 1997; Franke et al., 1997a,b; Frech et al., 1997) . In addition to direct binding of PtdIns-3,4-P 2 to the pleckstrin homology domain of Akt/PKB, there is some evidence to support a stress induced, PtdIns-3,4-P 2 independent Akt/PKB activation (Konishi et al., 1996) . Akt activity is also regulated by a PtdIns-3,4,5-P 3 activated kinase (PKBK or USK) (Alessi et al., 1997; Stokoe et al., 1997) . Activated Akt/PKB can protect cells against apoptosis and bypasses the need for PI3K activation, and kinase inactive Akt/PKB inhibits the survival eect of PI3K activation, showing that Akt/PKB activity is necessary and sucient for the anti-apoptotic function of PI3K.
Expression of activated Akt/PKB inhibited the activation of caspases, which are required for the apoptotic response to serum withdrawal (Kennedy et al., 1997) . Akt/PKB in this study did not block apoptosis in response to etoposide or UV. Thus, there are conditions where activation of Akt/PKB is not sucient to block pro-apoptotic stimuli. One mechanism for Akt/PKB protection against apoptosis is the phosphorylation and inactivation of Bad, a proapoptotic Bcl-2 family member (Franke et al., 1997a,b) .
cAMP elevation is a consequence of G protein coupled receptor activation. Engaging the B cell antigen receptor with antibodies or antigen in human tonsillar B cells or Ramos cells causes apoptosis in the absence of a co-stimulatory signal. This signal can come from the adenosine A2 receptor, which activates cAMP elevation, or through CD40. Activation of PKA using cell permeable cAMP analogs or stimulation of the adenosine A2 receptor blocked apoptosis as well (Sakata et al., submitted). Thus, B-cell death can be blocked by the activity of PKA (downstream of the adenosine A2 receptor) or by PKB (downstream of CD40). PKA and AKT/PKB share sequence homology, and could conceivably target the same downstream eectors to inhibit caspase activity and block apoptosis.
NF-kB is activated in response to many extracellular stimuli and is involved in the regulation of cytokine, chemokine, and growth factor genes and many other proteins involved in the response to extracellular stimuli (Baeuerle and Baltimore, 1996) . NF-kB has recently been shown to have signi®cant anti-apoptotic behavior. In cells de®cient in NF-kB (relA
), apoptotic responses to TNF-a and T cell antigen receptor activation were shown to be markedly enhanced (Beg and Baltimore, 1996; Wang et al., 1996a) . The expression of a dominant negative IkBa, an inhibitor of NF-kB, in cells also enhanced proapoptotic responses to extracellular stimuli (VanAntwerp et al., 1996) . The proposed mechanism for the anti-apoptotic eect of NF-kB is its transcriptional regulation of speci®c genes that are anti-apoptotic. Certainly, speci®c cytokine genes whose transcription is controlled by NF-kB are possible candidates. As is the case for many of the proteins involved in protecting against apoptosis, there is also evidence that with some cell types and apoptotic stimulants NF-kB can also be pro-apoptotic (Jung et al., 1995) . The recurrent ®nding that speci®c proteins can contribute to both anti-and pro-apoptotic responses demonstrates that integration of multiple signal inputs are involved in the commitment to apoptosis.
Raf is an upstream activator of ERKs, but it may have a role in the suppression of apoptosis that is independent of this function. It was recently demonstrated that Bcl-2 can target a GFP-Raf-1 fusion protein to the mitochondria (Wang et al., 1996b) . If Raf-1 was engineered to encode an outer mitochondrial membrane targeting sequence it was capable of protecting cells from apoptosis. Raf-1 was also shown to phosphorylate BAD, a pro-apoptotic Bcl-2 family member. In a separate study it was shown that survival factors such as IL-3 could stimulate the phosphorylation of BAD on serine residues (Zha et al., 1996) . The phosphorylated BAD no longer heterodimerized with Bcl-X L and remained bound to 14-3-3 proteins in the cytoplasm, eectively inhibiting its pro-apoptotic activity. The two studies suggest that the activity of Raf-1, if localized to the mitochondria, can regulate BAD activity. This would be a function for Raf-1 independent of its regulation of the ERK pathway.
Contrary to these ®ndings, it has also been demonstrated that Raf activation by Ras or expression of an activated Raf-CAAX construct (Kaumann-Zeh et al., 1997) was actually pro-apoptotic in c-Myc overexpressing Rat-1 cells. The Raf-1 pro-apoptotic response is predicted to occur at the plasma membrane whereas the anti-apoptotic response is localized at the mitochondria. These studies support the notion that speci®c signaling transduction proteins can be both pro-and anti-apoptotic and that subcellular location as well as downstream substrates can be important.
Coordinated signal transduction controls survival responses
It should be clear by this point that apoptosis is not a simple, linear chain of events, of the sort that is often depicted as a series of arrows, punctuated by the names of proteins, that leads inexorably from the plasma membrane to the nucleus and an inevitable outcome. Rather, the apoptotic response is an integration of several complex pathways, that includes crosstalk, feedback loops and bifurcations. This complexity is vital, in that inappropriate apoptosis, either too much or too little, can seriously damage the organism. To draw out even our currently sketchy knowledge as a chain of arrows would result in a diagram with no discernible pattern. Instead, we've chosen to show the signal transduction intermediates that are involved in apoptosis as existing along a continuum (Figure 1 ). Proteins whose names are shaded red are currently Figure 1 Several proteins have been proposed to have a role in the control of apoptosis. Pro-apoptotic signals are shown in red, anti-apoptotic signals are shown in green, and signals that can act as either pro-apoptotic or anti-apoptotic depending on the cell type are shown in yellow. The integration of these signals decide how the cell will respond to a given stimulus considered pro-apoptotic, and those in green are antiapoptotic. Those proteins that appear to have a dual nature are shaded in yellow. These proteins may appear to be pro-apoptotic in one cell type, and anti-apoptotic in others. It is this last group that the greatest possibility for clinical intervention exists, for the treatment of cancers, immune disorders and neurodegenerative diseases rely on our ability to manipulate apoptosis selectively in dierent cell types in vivo.
The immune response provides the most studied system where the coordinated activation of cell surface receptors controls survival. Ligation of the antigen receptors in T or B cells may be lethal. Ligation of a second receptor is required for survival (Ward, 1996; Valentine and Licciardi, 1992; Holder et al., 1993) . In the case of the T cell receptor the costimulatory receptor is often CD28 which regulates PI3K (Ward, 1996) . For the B cell receptor the costimulatory receptor may be CD19 which also regulates PI3K activity (Beckwith et al., 1996) or CD40, a member of the TNF receptor family (Valentine and Licciardi, 1992) . There currently exists more data for CD40 being protective relative to CD19 in B cells. For both T and B cells ligation of the antigen receptor without coordinated coligation of a second receptor results in apoptosis. In part, the basis for the apoptotic response is the loss of protective cytokine production and in some cases the expression of Fas ligand (Ivanov and NikolicZugic, 1997). Ligation and activation of Fas leads to the rapid activation of caspases that commit a cell to apoptosis. Additional or ampli®ed signals generated by co-stimulation of the antigen receptor and CD28 or CD40, for example, are able to maintain cytokine production and suppress the expression of Fas ligand. The intracellular signal pathways enhanced by costimulation may also function independently of cytokine production to sustain cell survival.
Central proteins in the cell death response as targets for regulation by signal transduction pathways Much of our understanding of the regulation of apoptosis originates with genetic experiments in the nematode C. elegans (Horvitz et al., 1994; Williams and Smith, 1993) . These experiments have de®ned three proteins, CED-9, CED-4 and CED-3, that are central to the death of cells during the development of the worm. A striking degree of similarity exists between the central pathway in C. elegans and that in higher organisms. The mammalian homologs of CED-3 are the caspases (Nagata, 1997) , CED9 homologs include Bcl-2 and its family members (Williams and Smith, 1993) , and the mammalian equivalent of CED4, Apaf-1, has recently been reported (Zou et al., 1997) . In the nematode CED-9 acts as a negative regulator of CED-4, which is required for the activation of CED-3 (Chinnaiyan et al., 1997) . In mammalian cells, this interaction is much more complex. Multiple Bcl-2 family members, some pro-apoptotic and others antiapoptotic, have been identi®ed. Activation of one of the many cloned caspases is eected by a heterotrimeric complex of Apaf-1 (mammalian CED-4 homolog), Apaf-2 (cytochrome c, released from the mitochondria) and Apaf-3 (an unidenti®ed 45 kDa protein). This complex interplay is simpli®ed in Figure  2 .
The regulation of these macromolecular assemblies to regulate caspase activation is a likely target for control by many inputs. Bcl-2 is known to be phosphorylated in response to dierent stimuli and can form several dierent protein complexes with other Bcl family members and other proteins including kinases (Reed, 1997) . The regulation of the Apaf complex is unknown but is probably also a point of regulation by signal transduction pathways. Signal transduction inputs that regulate the caspases have not been identi®ed, other than the assembly of death domain and death eector domain proteins on Fas (Muzio et al., 1996; Srinivasula et al., 1996) . Recently identi®ed inhibitors of caspases that bind to the active sites of the proteases are putative candidates for regulation by signal transduction inputs (Deveraux et al., 1997) .
As the critical members of the death response are further identi®ed, their regulation by signal transduction pathways including those involving Akt, ERK, MEKK1, JNK, NF-kB, etc. will probably come quickly. It should then become clearer how the cell uses an integrated circuitry of signals to control growth as well as apoptosis and the contribution of changes in this circuitry to human disease. At the same time, points of intervention will be revealed that will allow us to manipulate the apoptotic pathway selectively in certain cell types in vivo. Such a selective control over the apoptotic pathway may give us the key to the treatment of several diseases. 
